Luoheng Qin

Title: Luoheng Qin: Innovator in Pharmaceutical Compounds

Introduction

Luoheng Qin is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific medical conditions. With a total of 2 patents to his name, Qin's work is recognized for its potential impact on treating liver diseases.

Latest Patents

Qin's latest patents include innovative amino pyrimidine compounds that are useful as SSAO inhibitors. The present invention provides compounds of a specific formula, along with pharmaceutically acceptable salts of these compounds. Additionally, it outlines methods for treating patients suffering from liver disease and processes for preparing these compounds. This research highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Luoheng Qin is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Yi Wei and Mengyang Fan. Their collaborative efforts contribute to the dynamic research environment at Eli Lilly, fostering innovation and the development of new therapeutic solutions.

Conclusion

Luoheng Qin's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and ongoing research efforts are paving the way for new treatments that could significantly benefit patients with liver diseases.